IKERVIS 1 mg/mL eye drops, emulsion

• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

1. What IKERVIS is and what it is used for
2. What you need to know before you use IKERVIS
3. How to use IKERVIS
4. Possible side effects
5. How to store IKERVIS
6. Contents of the pack and other information

• if you are allergic to ciclosporin or any of the other ingredients of this medicine (listed in section 6).
• if you have had or have a cancer in or around your eye.
• if you have an eye infection.

Only use IKERVIS for dropping in your eye(s).

Talk to your doctor or pharmacist before using IKERVIS

• if you have previously had an eye infection by the herpes virus that might have damaged the transparent front part of the eye (cornea).
• if you are taking any medicines containing steroids.
• if you are taking any medicines to treat glaucoma.

Contact lenses can further damage the transparent front part of the eye (cornea). Therefore, you should remove your contact lenses at bedtime before using IKERVIS; you can reinsert them when you wake up.

IKERVIS should not be used in children and adolescents below 18 years old.

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.

Talk to your doctor if you are using eye drops containing steroids with IKERVIS as these might increase the risk of side effects.

IKERVIS eye drops should be used at least 15 minutes after any other eye drops are used.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

IKERVIS should not be used if you are pregnant.

If you could become pregnant you must use contraception while using this medicine.

IKERVIS is likely to be present in breast milk in very small amounts. If you are breast feeding talk to your doctor before using this medicine.

Your vision may be blurred immediately after using IKERVIS eye drops. If this happens, wait until your vision clears before you drive or use machines.

This medicine contains 0.05 mg cetalkonium chloride in 1 mL. You should remove contact lenses before using this medicine and you can reinsert them when you wake up. Cetalkonium chloride may cause eye irritation. If you feel abnormal eye sensation, stinging or pain in the eye after using this medicine, talk to your doctor.

Follow these instructions carefully and ask your doctor or pharmacist if there is anything you do not understand.

• Wash your hands.
• If you wear contact lenses, take them out at bedtime before using the drops; you can reinsert them when you wake up.
• Open the aluminium pouch, which contains 5 single-dose containers.
• Take one single-dose container from the aluminium pouch.
• Gently shake the single dose container prior to use.
• Twist off the cap (picture 1).
• Pull down your lower eyelid (picture 2).
• Tilt your head back and look up at the ceiling.
• Gently squeeze one drop of the medicine onto your eye. Make sure you do not touch your eye with the tip of the single-dose container.
• Blink a few times so that the medicine covers your eye.
• After using IKERVIS, press a finger into the corner of your eye by the nose and close gently the eyelids for 2 minutes (picture 3). This helps to stop IKERVIS getting into the rest of the body.
• If you use drops in both eyes, repeat the steps for your other eye.
• Discard the single dose container as soon as you have used it, even if there is still some medicine left in it.
• The remaining single-dose containers should be kept in the aluminium pouch.

If a drop misses your eye, try again.

If you use more IKERVIS than you should, rinse your eye with water. Do not put in any more drops until it is time for your next regular dose.

If you forget to use IKERVIS, continue with the next dose as planned. Do not use a double dose to make up for the forgotten dose. Do not use more than one drop each day in the affected eye(s).

If you stop using IKERVIS without speaking to your doctor, the inflammation of the transparent front part of your eye (known as keratitis) will not be controlled and could lead to impaired vision.

The most common side effects are in and around the eyes.

Very common (may affect more than 1 in 10 people)

• Eye pain,
• Eye irritation

Common (may affect up to 1 in 10 people)

• Redness of the eyelid,
• Watery eyes,
• Eye redness,
• Blurred vision,
• Swelling of the eyelid,
• Redness of the conjunctiva (thin membrane covering the front part of the eye),
• Itching in the eye

Uncommon (may affect up to 1 in 100 people)

• Discomfort in or around the eye when the drops are put into the eye, including feeling that there is something in the eye,
• Irritation or swelling of the conjunctiva (thin membrane covering the front part of the eye),
• Tear disorder,
• Eye discharge,
• Irritation or inflammation of the conjunctiva (thin membrane covering the front part of the eye),
• Inflammation of the iris (coloured part of the eye) or eyelid,
• Deposits in the eye,
• Abrasion to the outer layer of the cornea,
• Red or swollen eyelids,
• Cyst in the eyelid,
• Immune response or scarring in the cornea,
• Itching in the eyelid,
• Bacterial infection or inflammation of the cornea (transparent front part of the eye),
• Painful rash around the eye caused by the herpes zoster virus,
• Headache

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see contact details below).

Ireland

United Kingdom (Northern Ireland / Great Britain)

or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine.

• The active substance is ciclosporin. One millilitre of IKERVIS contains 1 mg of ciclosporin.
• The other ingredients are medium-chain triglycerides, cetalkonium chloride, glycerol, tyloxapol, poloxamer 188, sodium hydroxide (for pH adjustment) and water for injections.

IKERVIS is a milky white eye drops emulsion.

It is supplied in single-dose containers made of a low-density polyethylene (LDPE).

Each single-dose container contains 0.3 mL eye drops, emulsion.

The single-dose containers are wrapped in a sealed aluminium pouch.

Pack sizes: 30 and 90 single-dose containers.

Not all pack sizes may be marketed.